|
|
| |
Corticotrophin Carboxymethylcellulose Inj. BPC’ 73 300 IU |
| |
Is indicated in conditions where a stimulatory effect of ACTH on the adrenal cortex is desired.
Infantile spasm
Bronchial Asthma
Rheumotoid arithritis
Multiple sclerosis
Myasthenia gravis
Ulcerative colitis
Chronic active liver disease
Hay fever
Severe dermatitis
Hemorrhage
Collagen diseases
Septicemia
Nephrotic syndrome
Severe stress conditions
Adrenal function test
Lupus erythematosus disseminatus
|
| |
It is preferable given SC but it may also be administered IM.
LONG TERM TREATMENT
Adults
Usual Dose : 15-30 IU (0.25-0.5ml) SC every two days for protracted treatment.
Max. Dose : 60IU (1ml) daily or every two days.
The same effect as with 15 IU daily is also achieved with 30 IU every two days or 60 IU twice weekly.
In severe dermatological disorders : 60 IU or more daily.
Infants
Infantile spasm : 20 IU IM daily for 2 weeks.
Max. Dose : 30 IU and then 40 IU IM for additional 4 weeks.
SHORT TERM TREATMENT
Multiple Sclerosis, Myasthenia Gravis and Ulcerative Colitis : The dosage in short term or initial treatment may vary considerably, daily dose of up to 120 IU (2ml) subcutaneously for intensive treatment.
Renally Impaired Patients : Administer with caution. |
| |
Packing : |
5 Vials of 60 IU/ml |
|
|
